Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): A focus on selectivity over arginase

References

• Knipp M. How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target. Chembiochem 2006;7:879–889.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989;264:10205–10209.
   PubMed Web of Science ®Google Scholar
• Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999;43:542–548.
   PubMed Web of Science ®Google Scholar
• Tran CT, Fox MF, Vallance P, Leiper JM. Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 2000;68:101–105.
   PubMed Web of Science ®Google Scholar
• Vallance P, Leiper J. Blocking NO synthesis: How, where and why? Nat Rev Drug Discov 2002;1:939–950.
   PubMed Web of Science ®Google Scholar
• MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996;119:1533–1540.
   PubMed Web of Science ®Google Scholar
• Rossiter S, Smith CL, Malaki M, Nandi M, Gill H, Leiper JM et al. Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase. J Med Chem 2005;48:4670–4678.
   PubMed Web of Science ®Google Scholar
• Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O’Hara B et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 2007;13:198–203.
   PubMed Web of Science ®Google Scholar
• Schade D, Kotthaus J, Clement B. Modulating the NO generating system from a medicinal chemistry perspective: Current trends and therapeutic options in cardiovascular disease. Pharmacol Ther 2010;126:279–300.
   PubMed Web of Science ®Google Scholar
• Kotthaus J, Schade D, Muschick N, Beitz E, Clement B. Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads. Bioorg Med Chem 2008;16:10205–10209.
   PubMed Web of Science ®Google Scholar
• Wang Y, Monzingo AF, Hu S, Schaller TH, Robertus JD, Fast W. Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: Toward a targeted polypharmacology to control nitric oxide. Biochemistry 2009;48:8624–8635.
   PubMed Web of Science ®Google Scholar
• Lluis M, Wang Y, Monzingo AF, Fast W, Robertus JD. Characterization of C-alkyl amidines as bioavailable covalent reversible inhibitors of human DDAH-1. Chemmedchem 2011;6:81–88.
   PubMed Web of Science ®Google Scholar
• Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 1999;55:1015–1028.
   PubMed Web of Science ®Google Scholar
• Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S et al. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 2003;108:2000–2006.
   PubMed Web of Science ®Google Scholar
• Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007;34:906–911.
   PubMed Web of Science ®Google Scholar
• Forbes SP, Druhan LJ, Guzman JE, Parinandi N, Zhang L, Green-Church KB et al. Mechanism of 4-HNE mediated inhibition of hDDAH-1: Implications in no regulation. Biochemistry 2008;47:1819–1826.
   PubMed Web of Science ®Google Scholar
• Schade D, Kotthaus J, Clement B. Efficient synthesis of optically pure Nω-alkylated L-arginines. Synthesis 2008;15:2391–2397.
   Google Scholar
• Kotthaus J, Schade D, Töpker-Lehmann K, Beitz E, Clement B. N(delta)-methylated L-arginine derivatives and their effects on the nitric oxide generating system. Bioorg Med Chem 2008;16:2305–2312.
   PubMed Web of Science ®Google Scholar
• Knipp M, Vasák M. A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. Anal Biochem 2000;286:257–264.
   PubMed Web of Science ®Google Scholar
• Custot J, Boucher J-L, Vadon S, Guedes C, Dijols S, Dealforge M et al. Nω-hydroxyamino-α-amino acids as a new class of very strong inhibitors of arginases. J Biol Inorg Chem 1996;1:73–82.
   Web of Science ®Google Scholar
• Colleluori DM, Ash DE. Classical and slow-binding inhibitors of human type II arginase. Biochemistry 2001;40:9356–9362.
   PubMed Web of Science ®Google Scholar
• Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999;343 Pt 1:209–214.
   PubMed Web of Science ®Google Scholar
• Kotthaus J, Wahl B, Havemeyer A, Kotthaus J, Schade D, Garbe-Schönberg D et al. Reduction of Nω-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC). Biochem J 2010;433:383–391.
   Web of Science ®Google Scholar